Literature DB >> 8050315

Limonene in expired lung air of patients with liver disease.

M I Friedman1, G Preti, R O Deems, L S Friedman, S J Munoz, W C Maddrey.   

Abstract

As part of an effort to examine the relationship between chemosensory disturbance and oral chemistry, we analyzed expired lung air samples from a series of 24 patients with liver disease and 24 healthy controls using gas chromatography-mass spectrometry. Compared to samples from controls, lung air from patients with liver disease contained unusually high levels of limonene, a monoterpene that is a major component of the essential oil of citrus fruits (0.1 vs 7.0 micrograms/20 liters for controls and patients). Only half the patients showed high levels of limonene. Patients with noncholestatic liver disease were significantly more likely to have elevated lung air limonene levels than those with cholestatic liver disease (0.2 vs 13.8 micrograms/20 liters). Responses to food frequency and dietary behavior questionnaires indicated a pattern of diet selection and food preferences that were consistent with a dietary origin for the limonene in these patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050315     DOI: 10.1007/bf02087774

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Distaste for smoking; an early symptom in virus hepatitis.

Authors:  S LEIBOWITZ
Journal:  Rev Gastroenterol       Date:  1949-09

2.  Effect of d-limonene and related compounds on bile flow and biliary lipid composition in rats and dogs.

Authors:  R Kodama; H Inoue; K Noda; H Ide; H Yamamoto
Journal:  Life Sci       Date:  1976-11-15       Impact factor: 5.037

3.  Hyposmia in acute viral hepatitis.

Authors:  R I Henkin; F R Smith
Journal:  Lancet       Date:  1971-04-24       Impact factor: 79.321

4.  Volatile fatty acids in the breath of patients with cirrhosis of the liver.

Authors:  S Chen; V Mahadevan; L Zieve
Journal:  J Lab Clin Med       Date:  1970-04

5.  Mercaptans and dimethyl sulfide in the breath of patients with cirrhosis of the liver. Effect of feeding methionine.

Authors:  S Chen; L Zieve; V Mahadevan
Journal:  J Lab Clin Med       Date:  1970-04

6.  Gustation as a determinant of ingestion: methodological issues.

Authors:  R D Mattes
Journal:  Am J Clin Nutr       Date:  1985-04       Impact factor: 7.045

7.  Oral odors in early experimental gingivitis.

Authors:  J G Kostelc; G Preti; P R Zelson; L Brauner; P Baehni
Journal:  J Periodontal Res       Date:  1984-05       Impact factor: 4.419

8.  Studies on the metabolism of d-Limonene (p-Mentha-1,8-diene). III. Effects of d-Limonene on the lipids and drug-metabolizing enzymes in rat livers.

Authors:  T Ariyoshi; M Arakaki; K Ideguchi; Y Ishizuka; K Noda
Journal:  Xenobiotica       Date:  1975-01       Impact factor: 1.908

9.  Studies on the metabolism of d-limonene (p-mentha-1,8-diene). IV. Isolation and characterization of new metabolites and species differences in metabolism.

Authors:  R Kodama; T Yano; K Furukawa; K Noda; H Ide
Journal:  Xenobiotica       Date:  1976-06       Impact factor: 1.908

10.  The use of d-limonene preparation as a dissolving agent of gallstones.

Authors:  H Igimi; T Hisatsugu; M Nishimura
Journal:  Am J Dig Dis       Date:  1976-11
View more
  9 in total

1.  Comparison of volatile organic compound profiles in exhaled breath versus plasma headspace in different diseases.

Authors:  David Grove; Galen Miller-Atkins; Celia Melillo; Florian Rieder; Satya Kurada; Daniel M Rotroff; Adriano R Tonelli; Raed A Dweik
Journal:  J Breath Res       Date:  2020-05-27       Impact factor: 3.262

Review 2.  Human skin volatiles: a review.

Authors:  Laurent Dormont; Jean-Marie Bessière; Anna Cohuet
Journal:  J Chem Ecol       Date:  2013-04-25       Impact factor: 2.626

3.  Limonene in exhaled breath is elevated in hepatic encephalopathy.

Authors:  M E O'Hara; R Fernández Del Río; A Holt; P Pemberton; T Shah; T Whitehouse; C A Mayhew
Journal:  J Breath Res       Date:  2016-11-21       Impact factor: 3.262

4.  Exhaled breath analysis in hepatology: State-of-the-art and perspectives.

Authors:  Antonio De Vincentis; Umberto Vespasiani-Gentilucci; Anna Sabatini; Raffaele Antonelli-Incalzi; Antonio Picardi
Journal:  World J Gastroenterol       Date:  2019-08-14       Impact factor: 5.742

5.  Breath biomarkers of insulin resistance in pre-diabetic Hispanic adolescents with obesity.

Authors:  Mohammad S Khan; Suzanne Cuda; Genesio M Karere; Laura A Cox; Andrew C Bishop
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

6.  A pilot study for the prediction of liver function related scores using breath biomarkers and machine learning.

Authors:  Rakesh Kumar Patnaik; Yu-Chen Lin; Ashish Agarwal; Ming-Chih Ho; J Andrew Yeh
Journal:  Sci Rep       Date:  2022-02-07       Impact factor: 4.996

7.  Rapid "breath-print" of liver cirrhosis by proton transfer reaction time-of-flight mass spectrometry. A pilot study.

Authors:  Filomena Morisco; Eugenio Aprea; Vincenzo Lembo; Vincenzo Fogliano; Paola Vitaglione; Giovanna Mazzone; Luca Cappellin; Flavia Gasperi; Stefania Masone; Giovanni Domenico De Palma; Riccardo Marmo; Nicola Caporaso; Franco Biasioli
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

8.  Volatile Biomarkers in Breath Associated With Liver Cirrhosis - Comparisons of Pre- and Post-liver Transplant Breath Samples.

Authors:  R Fernández Del Río; M E O'Hara; A Holt; P Pemberton; T Shah; T Whitehouse; C A Mayhew
Journal:  EBioMedicine       Date:  2015-07-26       Impact factor: 8.143

9.  Breath Biopsy Assessment of Liver Disease Using an Exogenous Volatile Organic Compound-Toward Improved Detection of Liver Impairment.

Authors:  Giuseppe Ferrandino; Isabel Orf; Rob Smith; Marzia Calcagno; Anita Kaur Thind; Irene Debiram-Beecham; Megan Williams; Olga Gandelman; Alexandra de Saedeleer; Graham Kibble; Anne Marie Lydon; Chris A Mayhew; Max Allsworth; Billy Boyle; Marc P van der Schee; Michael Allison; Matthew Hoare; Victoria K Snowdon
Journal:  Clin Transl Gastroenterol       Date:  2020-09       Impact factor: 4.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.